In lung cancer, the downregulation of miR-34 leads to the upregulation of target genes such as MET, B-cell lymphoma (Bcl2), and platelet-derived growth factor receptor (PDGFR) [72,73,74]. Here, PDGFRB is linked to lung carcinoma.